Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

被引：1609

作者：

Inzucchi, S. E. ^{[2
,3
]}

Bergenstal, R. M. ^{[4
]}

Buse, J. B. ^{[5
]}

Diamant, M. ^{[6
]}

Ferrannini, E. ^{[7
]}

Nauck, M. ^{[8
]}

Peters, A. L. ^{[9
]}

Tsapas, A. ^{[10
]}

Wender, R. ^{[11
]}

Matthews, D. R. ^{[1
,12
,13
]}

机构：

[1] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England

[2] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA

[3] Yale New Haven Med Ctr, New Haven, CT 06504 USA

[4] Pk Nicollet, Int Diabet Ctr, Minneapolis, MN USA

[5] Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC USA

[6] Vrije Univ Amsterdam, Med Ctr, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands

[7] Univ Pisa, Sch Med, Dept Med, I-56100 Pisa, Italy

[8] Diabet Zentrum Bad Lauterberg, Bad Lauterberg Im Harz, Germany

[9] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA

[10] Aristotle Univ Thessaloniki, Dept Med 2, GR-54006 Thessaloniki, Greece

[11] Thomas Jefferson Univ, Jefferson Med Coll, Dept Family & Community Med, Philadelphia, PA 19107 USA

[12] Oxford Biomed Res Ctr, NIHR, Oxford, England

[13] Univ Oxford, Harris Manchester Coll, Oxford, England

来源：

DIABETOLOGIA | 2012年 / 55卷 / 06期

关键词：

DIPEPTIDYL PEPTIDASE-4 INHIBITORS; BLOOD-GLUCOSE CONTROL; COMPARING INSULIN DETEMIR; INCRETIN-BASED THERAPIES; LIFE-STYLE MODIFICATION; GLYCEMIC CONTROL; COMBINATION THERAPY; CLINICAL-TRIAL; HEART-FAILURE; BETA-CELL;

D O I：

10.1007/s00125-012-2534-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1577 / 1596

页数：20

共 134 条

[1] Current treatment of non-alcoholic fatty liver disease [J].

Ahmed, Mohamed H. ;

Byrne, Christopher D. .

DIABETES OBESITY & METABOLISM, 2009, 11 (03) :188-195

[2] Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control [J].

Akalin, S. ;

Berntorp, K. ;

Ceriello, A. ;

Das, A. K. ;

Kilpatrick, E. S. ;

Koblik, T. ;

Munichoodappa, C. S. ;

Pan, C. Y. ;

Rosenthall, W. ;

Shestakova, M. ;

Wolnik, B. ;

Woo, V. ;

Yang, W. Y. ;

Yilmaz, M. T. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (10) :1421-1425

[3] Nutrition recommendations and interventions for diabetes - A position statement of the American Diabetes Association [J].

不详 .

DIABETES CARE, 2008, 31 :S61-S78

[4] Importance of weight management in Type 2 diabetes: Review with meta-analysis of clinical studies [J].

Anderson, JW ;

Kendall, CWC ;

Jenkins, DJA .

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2003, 22 (05) :331-339

[5]

[Anonymous], 2008, Can J Diabetes, V32, pS1, DOI DOI 10.1503/CMAJ.080554

[6]

[Anonymous], 2005, Global guideline for Type 2 diabetes

[7] Effects of metformin in patients with poorly controlled insulin-treated type 2 diabetes mellitus -: A randomized, double-blind, placebo-controlled trial [J].

Avilés-Santa, L ;

Sinding, J ;

Raskin, P .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (03) :182-+

[8] Drug therapy - Metformin [J].

Bailey, CJ ;

Turner, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579

[9] Response to comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e54, 2011) [J].

Wysham, C. H. ;

Kirkman, M. S. .

DIABETES CARE, 2011, 34 (08) :1887-1887

[10] Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II) [J].

Bell, D. S. H. ;

Dharmalingam, M. ;

Kumar, S. ;

Sawakhande, R. B. .

DIABETES OBESITY & METABOLISM, 2011, 13 (09) :800-805

← 1 2 3 4 5 6 7 8 9 10 →